These data suggest that lunasin tends to inhibit production of the pro-angiogenesis cytokine VEGF, and this suppressive property was significantly effective in the Ad-CM model, resulting in the retardation of the migration of 4T1 breast cancer cells. This evidence concerns the gene VEGFA and breast cancer.